Zydus Lifesciences Ltd. - Research Center
532321 ZYDUSLIFE Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 8,731.60 | 7,981.90 | 7,790.40 | 6,347.40 | 6,037.40 |
| Operating profit | 2,454.40 | 1,918.10 | 2,319.10 | 1,423.10 | 1,629.80 |
| Interest | 278.20 | 134.90 | 70.90 | 233.90 | 89.60 |
| Gross profit | 2,724.60 | 1,961.90 | 2,327.10 | 2,038.60 | 2,099.50 |
| EPS (Rs) | 15.11 | 8.38 | 14.42 | 13.80 | 14.51 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 548.40 | 178.70 | 78.90 | 849.40 | 559.30 |
| Stock adjustment | 105.10 | -46.90 | -148.30 | 15.50 | -86.00 |
| Raw material | 2,703.50 | 2,629.00 | 2,346.40 | 1,838.30 | 1,755.80 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1,321.90 | 1,204.90 | 1,147.30 | 1,077.40 | 961.20 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 2,146.70 | 2,276.80 | 2,125.90 | 1,993.10 | 1,776.60 |
| Provisions made | - | - | - | - | - |
| Depreciation | 488.60 | 478.70 | 451.10 | 428.90 | 358.20 |
| Taxation | 503.00 | 306.00 | 212.30 | 204.10 | 301.50 |
| Net profit / loss | 1,529.20 | 857.90 | 1,476.20 | 1,412.90 | 1,485.70 |
| Extra ordinary item | -203.80 | -319.30 | -187.50 | 7.30 | 45.90 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 101.20 | 102.40 | 102.40 | 102.40 | 102.40 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 28.11 | 24.03 | 29.77 | 22.42 | 27.00 |
| GPM (%) | 29.36 | 24.04 | 29.57 | 28.33 | 31.83 |
| NPM (%) | 16.48 | 10.51 | 18.76 | 19.63 | 22.52 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis